IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

交易中 07-09 11:33:57 EDT

2.33

+0.13

+6.08%

最高2.39	最低2.26	成交量9.68万
今开2.26	昨收2.20	日振幅6.14%
总市值803.81万	流通市值702.43万	总股本344.42万
成交额22.60万	换手率3.22%	流通股本300.98万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":2.3338,"timestamp":1752075119318,"preClose":2.2,"halted":0,"volume":96770,"delay":0,"floatShares":3009793,"shares":3444200,"eps":-13.03071,"marketStatus":"交易中","change":0.1338,"latestTime":"07-09 11:33:57 EDT","open":2.26,"high":2.39,"low":2.255,"amount":225984.716582,"amplitude":0.061364,"askPrice":2.37,"askSize":500,"bidPrice":2.28,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-13.03071,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752091200000},"marketStatusCode":2,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.25,"preClose":2.2,"latestTime":"09:25 EDT","volume":3003,"amount":6743.003467199999,"timestamp":1752067513103},"postHourTrading":{"tag":"盘后","latestPrice":2.22,"preClose":2.2,"latestTime":"19:50 EDT","volume":4572,"amount":10151.025,"timestamp":1752018612395},"volumeRatio":2.660042},"requestUrl":"/m/hq/s/INAB","defaultTab":"news","newsList":[{"id":"2550578164","title":"In8Bio, Inc.盘中异动 临近收盘股价大涨5.24%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550578164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550578164?lang=zh_cn&edition=full","pubTime":"2025-07-09 03:58","pubTimestamp":1752004701,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日03时58分，In8Bio, Inc.股票出现异动，股价快速上涨5.24%。截至发稿，该股报2.21美元/股，成交量5.2228万股，换手率1.52%，振幅4.29%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709035822979eba76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709035822979eba76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2548529812","title":"In8Bio, Inc.盘中异动 下午盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548529812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548529812?lang=zh_cn&edition=full","pubTime":"2025-07-03 02:35","pubTimestamp":1751481308,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日02时35分，In8Bio, Inc.股票出现波动，股价快速拉升5.31%。截至发稿，该股报2.18美元/股，成交量15.5671万股，换手率4.52%，振幅5.80%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703023508a4cbab8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703023508a4cbab8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2543603712","title":"In8Bio, Inc.盘中异动 大幅跳水5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543603712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543603712?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:56","pubTimestamp":1750082212,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时56分，In8Bio, Inc.股票出现异动，股价大幅下跌5.31%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616215652a4ac3e77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616215652a4ac3e77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2543546592","title":"In8Bio, Inc.盘中异动 急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543546592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543546592?lang=zh_cn&edition=full","pubTime":"2025-06-13 00:17","pubTimestamp":1749745047,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日00时17分，In8Bio, Inc.股票出现波动，股价快速下跌5.12%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613001727a705a9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613001727a705a9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2542934872","title":"In8Bio, Inc.盘中异动 早盘急速下挫5.19%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542934872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542934872?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:51","pubTimestamp":1749563460,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时51分，In8Bio, Inc.股票出现异动，股价快速下跌5.19%。截至发稿，该股报2.92美元/股，成交量5.3605万股，换手率1.56%，振幅5.50%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102151019516611f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102151019516611f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2542801103","title":"In8Bio, Inc.盘中异动 急速下挫21.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542801103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542801103?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:31","pubTimestamp":1749475895,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时31分，In8Bio, Inc.股票出现异动，股价快速跳水21.10%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213135a700af3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213135a700af3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2540577770","title":"In8Bio, Inc.盘中异动 快速下跌5.39%报0.127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540577770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540577770?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:14","pubTimestamp":1748960095,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时14分，In8Bio, Inc.股票出现异动，股价大幅下跌5.39%。截至发稿，该股报0.127美元/股，成交量203.984万股，换手率2.25%，振幅5.46%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603221456a6f8c918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603221456a6f8c918&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2540795776","title":"In8Bio, Inc.盘中异动 早盘股价大跌9.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540795776?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:31","pubTimestamp":1748871100,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时31分，In8Bio, Inc.股票出现波动，股价大幅下挫9.38%。截至发稿，该股报0.134美元/股，成交量835.554万股，换手率9.20%，振幅0.20%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213140a6f7234f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213140a6f7234f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2539265736","title":"In8Bio, Inc.盘中异动 急速上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539265736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539265736?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:39","pubTimestamp":1748525974,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时39分，In8Bio, Inc.股票出现波动，股价快速上涨5.63%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292139349769e3b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292139349769e3b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2538464736","title":"In8Bio, Inc.盘中异动 早盘快速上涨5.66%报0.153美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538464736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538464736?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:31","pubTimestamp":1748352714,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时31分，In8Bio, Inc.股票出现异动，股价急速拉升5.66%。截至发稿，该股报0.153美元/股，成交量54.4262万股，换手率0.60%，振幅1.45%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505272131549504634a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505272131549504634a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2537815953","title":"In8Bio, Inc.盘中异动 下午盘快速拉升5.20%报0.140美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537815953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537815953?lang=zh_cn&edition=full","pubTime":"2025-05-24 02:04","pubTimestamp":1748023449,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日02时04分，In8Bio, Inc.股票出现波动，股价大幅上涨5.20%。截至发稿，该股报0.140美元/股，成交量63.3242万股，换手率0.70%，振幅6.85%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524020409aa2c98a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524020409aa2c98a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2537592890","title":"In8Bio, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537592890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537592890?lang=zh_cn&edition=full","pubTime":"2025-05-22 23:26","pubTimestamp":1747927601,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日23时26分，In8Bio, Inc.股票出现异动，股价快速拉升5.24%。截至发稿，该股报0.133美元/股，成交量20.4515万股，换手率0.23%，振幅4.13%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522232641a4886ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522232641a4886ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2536641940","title":"In8Bio, Inc.盘中异动 临近午盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536641940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536641940?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:39","pubTimestamp":1747755567,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时39分，In8Bio, Inc.股票出现波动，股价急速上涨5.36%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520233928975fae46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520233928975fae46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","NRXS","BK4082","BK4539","BK4139"],"gpt_icon":0},{"id":"2536680278","title":"In8Bio, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536680278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536680278?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:52","pubTimestamp":1747662776,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时52分，In8Bio, Inc.股票出现波动，股价快速下跌5.05%。截至发稿，该股报0.122美元/股，成交量22.9638万股，换手率0.25%，振幅4.90%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519215256a48428b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519215256a48428b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2536022317","title":"In8Bio, Inc.2025财年第一财季实现净利润-5.55百万美元，同比增加35.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536022317","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536022317?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:00","pubTimestamp":1747411214,"startTime":"0","endTime":"0","summary":"5月17日，In8Bio, Inc.公布财报，公告显示公司2025财年第一财季净利润为-5.55百万美元，同比增加35.16%；其中营业收入为0.00美元，每股基本收益为-0.07美元。从资产负债表来看，In8Bio, Inc.总负债5.99百万美元，其中短期债务1.24百万美元，资产负债比为3.32，流动比率为4.31。机构评级：截至2025年5月17日，当前有5家机构对In8Bio, Inc.目标价做出预测，其中目标均价为3.59美元，其中最低目标价为1.20美元，最高目标价为7.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000023a48117e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000023a48117e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB"],"gpt_icon":0},{"id":"2535231397","title":"In8Bio, Inc.盘中异动 股价大跌6.42%报0.124美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535231397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535231397?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:33","pubTimestamp":1747402383,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时33分，In8Bio, Inc.股票出现异动，股价大幅下挫6.42%。截至发稿，该股报0.124美元/股，成交量31.8852万股，换手率0.35%，振幅4.53%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213306a6e1b9ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213306a6e1b9ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2535582456","title":"In8Bio, Inc.盘中异动 早盘快速跳水18.68%报0.119美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535582456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535582456?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:32","pubTimestamp":1747315941,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时32分，In8Bio, Inc.股票出现波动，股价急速跳水18.68%。截至发稿，该股报0.119美元/股，成交量1175.47万股，换手率12.95%，振幅3.68%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213221a6e06d5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213221a6e06d5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2535020320","title":"In8Bio, Inc.盘中异动 股价大跌5.00%报0.152美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535020320?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:32","pubTimestamp":1747229527,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时32分，In8Bio, Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报0.152美元/股，成交量61.384万股，换手率0.68%，振幅2.63%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213207a6df08a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213207a6df08a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4007","BK4539","SEPN"],"gpt_icon":0},{"id":"2534454671","title":"In8Bio, Inc.盘中异动 快速下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534454671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534454671?lang=zh_cn&edition=full","pubTime":"2025-05-10 02:29","pubTimestamp":1746815384,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日02时29分，In8Bio, Inc.股票出现异动，股价急速下跌5.30%。截至发稿，该股报0.159美元/股，成交量38.4335万股，换手率0.47%，振幅5.24%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.82%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505100229459754c5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505100229459754c5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2533022650","title":"In8Bio, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533022650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533022650?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:37","pubTimestamp":1746553067,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时37分，In8Bio, Inc.股票出现异动，股价快速下挫5.16%。截至发稿，该股报0.158美元/股，成交量67.2618万股，换手率0.83%，振幅6.59%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为5.68%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507013748aa2c84e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507013748aa2c84e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":0.0628},{"period":"1month","weight":-0.4724},{"period":"3month","weight":-0.5198},{"period":"6month","weight":-0.7654},{"period":"1year","weight":-0.9108},{"period":"ytd","weight":-0.7149}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于发现、开发和商业化用于实体和液体肿瘤的gamma-delta T细胞候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.075455},{"month":2,"riseRate":0.5,"avgChangeRate":-0.045373},{"month":3,"riseRate":0.25,"avgChangeRate":-0.169384},{"month":4,"riseRate":0.5,"avgChangeRate":-0.068431},{"month":5,"riseRate":0.5,"avgChangeRate":0.261664},{"month":6,"riseRate":0.25,"avgChangeRate":-0.322353},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016259},{"month":8,"riseRate":0.25,"avgChangeRate":-0.195936},{"month":9,"riseRate":0.25,"avgChangeRate":-0.177333},{"month":10,"riseRate":0.5,"avgChangeRate":0.013341},{"month":11,"riseRate":0.25,"avgChangeRate":-0.10029},{"month":12,"riseRate":0.5,"avgChangeRate":0.145873}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}